EyePoint Pharmaceuticals's total assets for Q4 2024 were $418.46M, an increase of 39.06% from the previous quarter. EYPT total liabilities were $81.96M for the fiscal quarter, a -0.27% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.